BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)

Part of paid clinical trials in New York, New York.

Sponsor
Icahn School of Medicine at Mount Sinai
Study ID
NCT07786012
Phase
PHASE4
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cesarean Delivery

Eligibility Criteria

Sex
ALL
Age
19 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • buprenorphine — DRUG
    60 mcg buprenorphine intrathecal
  • morphine — DRUG
    125mcg morphine intrathecal

Study Details

In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.

Key Dates

First listed
Aug 25, 2026
Start date
Aug 31, 2026
Status verified
Aug 2026
Primary completion
Aug 31, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
180 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Buprenorphine
    Patients receive 60 mcg buprenorphine as a part of their spinal medications.
  • Active Comparator: Morphine
    Patients receive 125 mcg morphine as a part of their spinal medications

Primary Outcome Measure

Morphine equivalents administered within 24 hours after spinal administration [ Time Frame: 24 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mount Sinai HospitalNew YorkNew York10029
Daniel Katz, MD
[email protected]
212-241-7475
Daniel Katz (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Mount Sinai Hospital· New York, NY

Related Studies